News

A growing body of research supports non-pharmacological treatments, particularly exercise, as effective in alleviating primary dysmenorrhea symptoms.

A long-term study finds sotatercept continues to improve outcomes in patients with pulmonary arterial hypertension, with manageable safety risks.

Understand how diabetes may raise bone density over time, but fracture risk remains.

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

At least 60% of liver cancer diagnoses are linked to modifiable risk factors and could be prevented through global interventions

The study found that patients receiving the AR-PRISE intervention experienced significant improvements in symptom control, particularly over the longer term.

This study focused on eGDR, a widely accessible proxy for insulin sensitivity derived from waist circumference, hypertension status, and HbA1c levels.

Dialysis-requiring AKI after PCI remains rare but deadly, with high mortality and complication rates demanding vigilant care.